Company: MHLA
Filing Date: 2025-03-20
Form Type: 10-K/A
Source: 0001412100-25-000020
Chunk: 19

Company: Maiden Holdings, Ltd.
Filing Date: 2025-03-20
Form: 10-K/A
Chunk 19
---
 performance-based equity grants was not viewed as probable at the time of grant, there is no grant date fair value associated with these awards. Please see the “Outstanding Equity Awards at Fiscal Year-End 2024” for further information regarding the March 7, 2024 performance-based equity grants.            |
| (5) |     | Represents the aggregate grant date fair market value of non-performance-based restricted share awards granted to the named executive officer as determined in accordance with Accounting Standards Codification Topic No. 718, "Compensation Stock Discussion," using the assumptions described in Note 14 to the Financial Statements included in our Annual Report on Form 10-K filed with the SEC on March 10, 2025. At the discretion of the Compensation Committee on March 17, 2023, Mr. Metz was granted 169,565 restricted shares that will vest 50% on the first anniversary of the grant, and 50% on the second anniversary of the grant. The value of the restricted shares at grant date fair market value for Mr. Metz was $390,000. At the discretion of the Compensation Committee on March 17, 2023, Mr. Metz was also granted 112,745 common shares pursuant to the 2019 Omnibus Incentive Plan with immediate vesting with a grant date fair market value of $259,315. Because the achievement of the performance goals associated with the March 17, 2023 performance-based equity grants was not viewed as probable at the time of grant, there is no grant date fair value associated with these awards. Please see “Outstanding Equity Awards at Fiscal Year-End 2024” for further information regarding the March 17, 2023 performance-based equity grants.                                                                                                                                                                         |
| (6) |     | Represents the aggregate grant date fair market value of non-performance based restricted share awards granted to the named executive officer as determined in accordance with Accounting Standards Codification Topic No. 718, "Compensation Stock Discussion," using the assumptions described in Note 14 to the Financial Statements included in our Annual Report on Form 10-K filed with the SEC on March 10, 2025. At the discretion of the Compensation Committee on March 22, 2024, Mr. Jarman was granted 107,527 restricted shares, vesting 100% on March 31, 2026. The restricted shares were awarded with voting and dividend rights. The value of the restricted shares at grant date fair market value